AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Sit DC-M 500 Tablet

Prescription Icon
Prescription Required

Marketer

FDC Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sit DC-M 500 Tablet

Duo-Control 500mg tablets combine two medications to effectively manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Duo-Control 500mg may be used alone or with other antidiabetic therapies, and works optimally with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering existing health status, blood sugar readings, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise plan is crucial for optimal diabetes control, as lifestyle significantly impacts management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential risk, especially when combined with insulin or sulfonylureas; patients should be familiar with its recognition and treatment. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or excessive alcohol consumption. Pregnant or lactating individuals require medical consultation before use. Potential drug interactions exist; therefore, disclose all medications to your doctor to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effects. Your doctor will monitor kidney function and blood sugar levels throughout treatment.

Primary Ingredients of Sit DC-M 500 Tablet

No text provided. Please provide the text you want me to rephrase.

Uses of Sit DC-M 500 Tablet

Managing type 2 diabetes

Major Benefits of Sit DC-M 500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sit DC-M 500 Tablet with a meal.

Common Side effects of Sit DC-M 500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sit DC-M 500 Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Sit DC-M 500 Tablet should be administered with a meal.

How Sit DC-M 500 Tablet works:

Sitagliptin and metformin, combined as Sit DC-M 500 Tablet, offer enhanced blood glucose management. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action results in superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Sit DC-M 500 Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sit DC-M 500 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Consult your doctor for guidance.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sit DC-M 500 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sit DC-M 500 Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sit DC-M 500 Tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should not take Sit DC-M 500 Tablets; this medication poses a likely risk to their health. Medical advice is recommended.

What if you forget to take Sit DC-M 500 Tablet :

Should you forget a dose of Sit DC-M 500 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sit DC-M 500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sit DC-M 500 Tablet

Sit DC-M 500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Sit DC-M 500 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues like numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Sit DC-M 500 Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sit DC-M 500 Tablet components or excipients, or those suffering from severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sit DC-M 500 Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitagliptin + Metformin (Sit DC-M 500 Tablet) can cause lactic acidosis (MALA), a serious medical condition resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol, hence its avoidance in these groups. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sit DC-M 500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sit DC-M 500 Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sit DC-M 500 Tablet components or excipients should not use this medication. Similarly, it should be avoided by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sit DC-M 500 Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sit DC-M 500 Tablet) can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged use of Sit DC-M 500 Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, supplemental vitamin B12 is recommended annually by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sit DC-M 500 Tablet combines sitagliptin and metformin to treat type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sit DC-M 500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sit DC-M 500 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Sit DC-M 500 Tablets is unsafe and may raise the risk of lactic acidosis.
Sitagliptin/Metformin (Sit DC-M 500 Tablet) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged Sit DC-M 500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia and neurological issues, including numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the label's instructions. Discard any unused medication and keep it out of reach of children, pets, and others.
Sit DC-M 500 Tablet
89
MRP 104
14% off